Contract manufacturing facility additions: round-up

Related tags Boehringer ingelheim

Contract manufacturing facility additions: round-up
Outsourcing-Pharma.com brings you a round-up of the latest contract manufacturing facility additions, including news from Boehringer Ingelheim, Cambridge Major Laboratories, and B. Braun Group.

German drugmaker Boehringer Ingelheim​ has developed a way of managing biomanufacturing that can be applied to any single use production platform on the market.

The approach – which will be available to all the firm’s contract biomanufacturing customers – will allow clients to set-up different commercially available systems under the same roof, all operated by the same experts.

Boehringer says the platform, which will be based in its mammalian facilities, means seamless process transfers. It is part of its “Lean-to-Clinic” ​program, which aims to advance from gene to drug product in 16 months.

“We have gathered years of experiences from different single use systems in our expert groups and could therefore form a truly unique single use platform for upstream- and downstream processes,”​ said Hitto Kaufmann, VP of process science, Germany.

Cambridge Major Laboratories (CML) ​has expanded its active pharmaceutical ingredient (API) facility in Germantown, Wisonsin, in what it says is a response to a boom in demand for late phase clinical production services.

Under the plans, the company will add “significant”​ extra reactor capacity and isolation equipment.

Brian Scanlan, president and CEO said the undisclosed investment is a bid to meet an industry demand for speedy manufacturing in late phases.

“By making these new investments, we show our commitment to support our loyal client base at the most critical point, when quality and timely delivery are imperative,”​ he said.

B. Braun Group​ has completed a new 98,000 sq ft parenteral solutions factory in Barcelona, Spain.

The facility includes three continuous processing production lines which operate around the clock, including four 30,000ltr manufacturing tanks, two 15,000ltr tanks and three bottling lines.

It works on lean infusion factory technology (LIFT).

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars